(R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol hydrochloride - CAS 521284-21-9
Catalog: |
BB027720 |
Product Name: |
(R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol hydrochloride |
CAS: |
521284-21-9 |
Synonyms: |
(R)-2-((2-(4-Nitrophenyl)-ethyl)amino)-1-phenylethanol monohydrochloride; Mirabegron Impurity F (Hydrochloride Salt) |
Related CAS: | 223673-34-5 (free base)
|
IUPAC Name: | (1R)-2-[2-(4-nitrophenyl)ethylamino]-1-phenylethanol;hydrochloride |
Description: | An impurity of Mirabegron. Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity. |
Molecular Weight: | 322.78 |
Molecular Formula: | C16H19ClN2O3 |
Canonical SMILES: | C1=CC=C(C=C1)[C@H](CNCCC2=CC=C(C=C2)[N+](=O)[O-])O.Cl |
InChI: | InChI=1S/C16H18N2O3.ClH/c19-16(14-4-2-1-3-5-14)12-17-11-10-13-6-8-15(9-7-13)18(20)21;/h1-9,16-17,19H,10-12H2;1H/t16-;/m0./s1 |
InChI Key: | LUAUJCGKCGBAKA-NTISSMGPSA-N |
Melting Point: | 202-205 °C |
Solubility: | Soluble in DMSO (Slightly), Water (Slightly) |
Appearance: | Pale Yellow Solid |
LogP: | 4.17660 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
KR-20210073972-A | A new process for the preparation of (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol | 20191211 |
CN-109456277-A | A kind of preparation method of Mirabegron | 20181029 |
CN-104496841-B | Method for synthesizing mirabegron intermediate | 20141126 |
EP-3177589-A1 | Method for the synthesis of mirabegron and its derivatives | 20140806 |
EP-3177589-B1 | Method for the synthesis of mirabegron and its derivatives | 20140806 |
Complexity: | 305 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 1 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 322.1084202 |
Formal Charge: | 0 |
Heavy Atom Count: | 22 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 3 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 322.1084202 |
Rotatable Bond Count: | 6 |
Topological Polar Surface Area: | 78.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
-
Catalog: BB080017
(1-Benzylpyrrolidine-2,5-diyl)dimethanol
Detail
-
Catalog: BB051882
(1-Cyclopentyl-1H-pyrazol-3-yl)methanol
Detail
-
Catalog: BB050668
(1-(2,2,2-Trifluoroethyl)-1H-pyrazol-4-yl)methanol
Detail
-
Catalog: BB017049
(1-Allylcyclobutyl)methanol
Detail
-
Catalog: BB040898
(+)-Taddol
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
-
Catalog: BB051687
(1-(2,2,2-Trifluoroethyl)-1H-pyrazol-5-yl)methanol
Detail
-
Catalog: BB026447
(±)-3-Benzyloxy-1,2-propanediol
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Alcohols and Derivatives
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS